Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Myocardial Infarction and meta-analysis and CYP2C19[original query] |
---|
Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel. Molecular biology reports 2011 Mar 38 (3): 1697-702. Jin Bo, Ni Huan-Chun, Shen Wei, Li Jian, Shi Hai-Ming, Li Yo |
The gain-of-function variant allele CYP2C19*17: a double-edged sword between thrombosis and bleeding in clopidogrel-treated patients. Journal of thrombosis and haemostasis : JTH 2011 Nov . Li Y, Tang HL, Hu YF, Xie HG |
CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: is clinical testing helpful? Indian heart journal 2012 64 (4): 4. Singh M, Shah T, Adigopula S, Molnar J, Ahmed A, Khosla S, Arora R |
Meta-analysis of cytochrome P450 2C19 polymorphism and risk of adverse clinical outcomes among coronary artery disease patients of different ethnic groups treated with clopidogrel. The American journal of cardiology 2012 Aug 110 (4): 502-8. Jang Jae-Sik, Cho Kyoung-Im, Jin Han-Young, Seo Jeong-Sook, Yang Tae-Hyun, Kim Dae-Kyeong, Kim Dong-Soo, Seol Sang-Hoon, Kim Doo-Il, Kim Bo-Hyun, Park Yong Hyun, Je Hyung-Gon, Jeong Young-Hoon, Lee Seung-Wh |
Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects. Archives of cardiovascular diseases 2013 Oct 106 (10): 517-27. Mao Liu, Jian Chen, Changzhi Liu, Dan Huang, Suihua Huang, Wenyi Tang, Wei |
Efficacy and safety of CYP2C19 genotype in stroke or transient ischemic attack patients treated with clopidogrel monotherapy or clopidogrel plus aspirin: Protocol for a systemic review and meta-analysis. Medicine 2018 6 97 (24): e11060. Yao Jia-Chen, Cui Min, Pan Mang-Mang, Gu Zhi-Chun, Li Wen-Y |
CYP2C19 pharmacogenetics in patients undergoing coronary stent placement: Is it time to test everyone? Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2019 6 93 (7): 1253-1254. Price Dana J, Levy Michael |
The efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy compared with conventional antiplatelet therapy in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials. Platelets 2020 6 31 (8): 971-980. Lyu Si-Qi, Yang Yan-Min, Zhu Jun, Wang Juan, Wu Shuang, Zhang Han, Shao Xing-Hui, Ren Jia-Me |
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y Inhibitor Therapy: A Meta-Analysis. JACC. Cardiovascular interventions 2021 Apr 14 (7): 739-750. Pereira Naveen L, Rihal Charanjit, Lennon Ryan, Marcus Gil, Shrivastava Sanskriti, Bell Malcolm R, So Derek, Geller Nancy, Goodman Shaun G, Hasan Ahmed, Lerman Amir, Rosenberg Yves, Bailey Kent, Murad M Hassan, Farkouh Michael |
High-Dose Clopidogrel versus Ticagrelor in CYP2C19 intermediate or poor metabolizers after percutaneous coronary intervention: A Meta-Analysis of Randomized Trials. Journal of clinical pharmacy and therapeutics 2022 4 47 (8): 1112-1121. Sheng Xiao-Yan, An Hui-Jie, He Yong-Yang, Ye Yong-Feng, Zhao Jia-Lan, Li S |
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Cardiovascular revascularization medicine : including molecular interventions 2022 1 41 115-121. Malik Aaqib H, Gupta Rahul, Chakraborty Sandipan, Mahajan Pranav, Bandyopadhyay Dhrubajyoti, Yandrapalli Srikanth, Zaid Syed, Sreenivasan Jayakumar, Chaturvedi Abhishek, Mehta Sanjay S, Vyas Apurva V, Patel Nainesh C, Combs William G, Ahmad Has |
- Page last reviewed:Feb 1, 2024
- Page last updated:May 06, 2024
- Content source: